Telomerase inhibitors for the treatment of cancer: the current perspective

Author： Perry Philip J   Arnold John RP   Jenkins Terence C  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.12, 2001-12, pp. : 2141-2156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design of Telomerase Inhibitors for the Treatment of Cancer

By  

Current Pharmaceutical Design, Vol. 8, Iss. 27, 2002-12 ,pp. : 2491-2504

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in the development of telomerase inhibitors for the treatment of cancer

By Perry P.J.   Jenkins T.C.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 1981-2008

Informa Healthcare

Access to resources Recommend Favorite

Current Acetylcholinesterase-Inhibitors: A Neuroinformatics Perspective

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 3, 2014-04 ,pp. : 391-401

Bentham Science Publishers

Access to resources Recommend Favorite

Telomerase as Drug and Drug Target for the Treatment of Thyroid Cancer

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 3, 2004-09 ,pp. : 253-256

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis inhibitors in the treatment of cancer

By Rhee Jay   Hoff Paulo M  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1701-1711

Informa Healthcare

Access to resources Recommend Favorite